Hillary S. Sloane, James P. Landers, Kimberly A. Kelly 

Slides:



Advertisements
Similar presentations
Measurement of Relative Copy Number of CDKN2A/ARF and CDKN2B in Bladder Cancer by Real-Time Quantitative PCR and Multiplex Ligation-Dependent Probe Amplification.
Advertisements

CyclinD1/CyclinD3 Ratio by Real-Time PCR Improves Specificity for the Diagnosis of Mantle Cell Lymphoma Carol D. Jones, Katherine H. Darnell, Roger A.
Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival Ryan K. Van Laar The.
A Melting Curve Analysis–Based PCR Assay for One-Step Genotyping of β- Thalassemia Mutations  Fu Xiong, Qiuying Huang, Xiaoyun Chen, Yuqiu Zhou, Xinhua.
Reality of Single Circulating Tumor Cell Sequencing for Molecular Diagnostics in Pancreatic Cancer  Colin M. Court, Jacob S. Ankeny, Shonan Sho, Shuang.
The Use of COLD-PCR and High-Resolution Melting Analysis Improves the Limit of Detection of KRAS and BRAF Mutations in Colorectal Cancer  Irene Mancini,
Comparison of Clinical Targeted Next-Generation Sequence Data from Formalin-Fixed and Fresh-Frozen Tissue Specimens  David H. Spencer, Jennifer K. Sehn,
Carol Beadling, Tanaya L. Neff, Michael C
Simultaneous Genotyping of α-Thalassemia Deletional and Nondeletional Mutations by Real-Time PCR–Based Multicolor Melting Curve Analysis  Qiuying Huang,
Sensitive Detection of KRAS Mutations in Archived Formalin-Fixed Paraffin-Embedded Tissue Using Mutant-Enriched PCR and Reverse-Hybridization  Christoph.
Detection of Low-Level KRAS Mutations Using PNA-Mediated Asymmetric PCR Clamping and Melting Curve Analysis with Unlabeled Probes  Ji Eun Oh, Hee Sun.
Single-Color Digital PCR Provides High-Performance Detection of Cancer Mutations from Circulating DNA  Christina Wood-Bouwens, Billy T. Lau, Christine.
Impact of Mutation Type and Amplicon Characteristics on Genetic Diversity Measures Generated Using a High-Resolution Melting Diversity Assay  Matthew.
Genome-Wide Identification and Validation of a Novel Methylation Biomarker, SDC2, for Blood-Based Detection of Colorectal Cancer  TaeJeong Oh, Nayoung.
Suppression of Wild-Type Amplification by Selectivity Enhancing Agents in PCR Assays that Utilize SuperSelective Primers for the Detection of Rare Somatic.
Detection of HIV-1 Minority Variants Containing the K103N Drug-Resistance Mutation Using a Simple Method to Amplify RNA Targets (SMART)  Kenneth Morabito,
Multiplex Preamplification of Serum DNA to Facilitate Reliable Detection of Extremely Rare Cancer Mutations in Circulating DNA by Digital PCR  Jennifer.
A Multiplex SNaPshot Assay as a Rapid Method for Detecting KRAS and BRAF Mutations in Advanced Colorectal Cancers  Sandrine Magnin, Erika Viel, Alice.
Establishment and Study of Different Real-Time Polymerase Chain Reaction Assays for the Quantification of Cells with Deletions of Chromosome 7  Elia Mattarucchi,
Elena Castellanos-Rizaldos, Cloud Paweletz, Chen Song, Geoffrey R
Molecular Analysis of Circulating Cell-Free DNA from Lung Cancer Patients in Routine Laboratory Practice  Stephan Bartels, Sascha Persing, Britta Hasemeier,
Stephanie A. Boccoz, Gaelle C. Le Goff, Celine A. Mandon, Benjamin P
A Melting Curve Analysis–Based PCR Assay for One-Step Genotyping of β- Thalassemia Mutations  Fu Xiong, Qiuying Huang, Xiaoyun Chen, Yuqiu Zhou, Xinhua.
Reality of Single Circulating Tumor Cell Sequencing for Molecular Diagnostics in Pancreatic Cancer  Colin M. Court, Jacob S. Ankeny, Shonan Sho, Shuang.
Comparison of High-Resolution Melting Analysis, TaqMan Allelic Discrimination Assay, and Sanger Sequencing for Clopidogrel Efficacy Genotyping in Routine.
Ken B. Waites, Li Xiao, Vanya Paralanov, Rose M. Viscardi, John I
Simultaneous Genotyping of α-Thalassemia Deletional and Nondeletional Mutations by Real-Time PCR–Based Multicolor Melting Curve Analysis  Qiuying Huang,
Sensitive Detection of KRAS Mutations in Archived Formalin-Fixed Paraffin-Embedded Tissue Using Mutant-Enriched PCR and Reverse-Hybridization  Christoph.
Detection of KRAS and BRAF Mutations in Colorectal Carcinoma
Assessment of EGFR Mutation Status in Lung Adenocarcinoma by Immunohistochemistry Using Antibodies Specific to the Two Major Forms of Mutant EGFR  Marie.
Patrick R. Murray  The Journal of Molecular Diagnostics 
Detection of an Apparent Homozygous 3120G>A Cystic Fibrosis Mutation on a Routine Carrier Screen  Denise LaMarche Heaney, Patrick Flume, Lauren Hamilton,
Christine L. Baker, Cecily P. Vaughn, Wade S. Samowitz 
A Novel and Reliable Method to Detect Microsatellite Instability in Colorectal Cancer by Next-Generation Sequencing  Lizhen Zhu, Yanqin Huang, Xuefeng.
Driver Gene Mutations in Stools of Colorectal Carcinoma Patients Detected by Targeted Next-Generation Sequencing  Gemma Armengol, Virinder K. Sarhadi,
Robyn P. Hickerson, Sancy A. Leachman, Lana N
Isothermal Strand-Displacement Polymerase Reaction for Visual Detection of the Southeast Asian–Type Deletion of α-Thalassemia  Luxin Yu, Wei Wu, Puchang.
Jamal H. Carter, Samantha N. McNulty, Patrick J. Cimino, Catherine E
Multiplex Amplification Coupled with COLD-PCR and High Resolution Melting Enables Identification of Low-Abundance Mutations in Cancer Samples with Low.
Benjamin P. Song, Surbhi Jain, Selena Y. Lin, Quan Chen, Timothy M
KRAS Mutation The Journal of Molecular Diagnostics
A Multi-Site Study for Detection of the Factor V (Leiden) Mutation from Genomic DNA Using a Homogeneous Invader Microtiter Plate Fluorescence Resonance.
Absence of the Caveolin-1 P132L Mutation in Cancers of the Breast and Other Organs  Shinya Koike, Yasuhiro Kodera, Akimasa Nakao, Hiroji Iwata, Yasushi.
Development of a Quantitative Real-Time Polymerase Chain Reaction Assay for the Detection of the JAK2 V617F Mutation  Elizabeth C. Wolstencroft, Katy.
Multiplex Bead Suspension Array for Screening Neisseria gonorrhoeae Antibiotic Resistance Genetic Determinants in Noncultured Clinical Samples  Sergey.
Highly Sensitive Droplet Digital PCR Method for Detection of EGFR-Activating Mutations in Plasma Cell–Free DNA from Patients with Advanced Non–Small Cell.
Technical Validation of a Next-Generation Sequencing Assay for Detecting Clinically Relevant Levels of Breast Cancer–Related Single-Nucleotide Variants.
A Commercial Real-Time PCR Kit Provides Greater Sensitivity than Direct Sequencing to Detect KRAS Mutations  Bárbara Angulo, Elena García-García, Rebeca.
Multiplexed High Resolution Melting Assay for Versatile Sample Tracking in a Diagnostic and Research Setting  Céline Helsmoortel, R. Frank Kooy, Geert.
Multiplex Amplification Coupled with COLD-PCR and High Resolution Melting Enables Identification of Low-Abundance Mutations in Cancer Samples with Low.
Detection of Common Disease-Causing Mutations in Mitochondrial DNA (Mitochondrial Encephalomyopathy, Lactic Acidosis with Stroke-Like Episodes MTTL
An Allele-Specific PCR System for Rapid Detection and Discrimination of the CYP2C19∗4A, ∗4B, and ∗17 Alleles  Stuart A. Scott, Qian Tan, Usman Baber,
Detection of the JAK2 V617F Mutation by LightCycler PCR and Probe Dissociation Analysis  Marla Lay, Rajan Mariappan, Jason Gotlib, Lisa Dietz, Siby Sebastian,
Ye Bang-Ce, Chu Xiaohe, Fan Ye, Li Songyang, Yin Bincheng, Zuo Peng 
A Novel Method for Creating Artificial Mutant Samples for Performance Evaluation and Quality Control in Clinical Molecular Genetics  Michael Jarvis, Ramaswamy.
Development of an Allele-Specific Real-Time PCR Assay for Discrimination and Quantification of p63 R279H Mutation in EEC Syndrome  Vanessa Barbaro, Letizia.
Performance and Clinical Evaluation of a Sensitive Multiplex Assay for the Rapid Detection of Common NPM1 Mutations  Michael Hafez, Fei Ye, Keith Jackson,
Rapid and Sensitive Real-Time Polymerase Chain Reaction Method for Detection and Quantification of 3243A>G Mitochondrial Point Mutation  Rinki Singh,
Amplification Refractory Mutation System, a Highly Sensitive and Simple Polymerase Chain Reaction Assay, for the Detection of JAK2 V617F Mutation in Chronic.
Danielle C. Smith, Alina Esterhuizen, Jacquie Greenberg 
A Rapid and Reliable Test for BRCA1 and BRCA2 Founder Mutation Analysis in Paraffin Tissue Using Pyrosequencing  Liying Zhang, Tomas Kirchhoff, Cindy.
A Platform for Rapid Detection of Multiple Oncogenic Mutations With Relevance to Targeted Therapy in Non–Small-Cell Lung Cancer  Zengliu Su, Dora Dias-Santagata,
Novel Method for PIK3CA Mutation Analysis
Evaluation of High-Resolution Melting Analysis as a Diagnostic Tool to Detect the BRAF V600E Mutation in Colorectal Tumors  Martin Pichler, Marija Balic,
Optimized Allele-Specific Real-Time PCR Assays for the Detection of Common Mutations in KRAS and BRAF  Alois H. Lang, Heinz Drexel, Simone Geller-Rhomberg,
Two Novel Methods for Rapid Detection and Quantification of DNMT3A R882 Mutations in Acute Myeloid Leukemia  Melissa Mancini, Syed Khizer Hasan, Tiziana.
Custom Design of a GeXP Multiplexed Assay Used to Assess Expression Profiles of Inflammatory Gene Targets in Normal Colon, Polyp, and Tumor Tissue  Janice.
Comparison of Sanger Sequencing, Pyrosequencing, and Melting Curve Analysis for the Detection of KRAS Mutations  Athanasios C. Tsiatis, Alexis Norris-Kirby,
Improved Detection of the KIT D816V Mutation in Patients with Systemic Mastocytosis Using a Quantitative and Highly Sensitive Real-Time qPCR Assay  Thomas.
Optimized Allele-Specific Real-Time PCR Assays for the Detection of Common Mutations in KRAS and BRAF  Alois H. Lang, Heinz Drexel, Simone Geller-Rhomberg,
Presentation transcript:

Hybridization-Induced Aggregation Technology for Practical Clinical Testing  Hillary S. Sloane, James P. Landers, Kimberly A. Kelly  The Journal of Molecular Diagnostics  Volume 18, Issue 4, Pages 546-553 (July 2016) DOI: 10.1016/j.jmoldx.2016.02.004 Copyright © 2016 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 1 Assay principles. Unpurified PCR product is added to a microwell containing probe-conjugated microbeads. A wild-type target hybridizes efficiently to both probes, inducing bead aggregation. Hybridization of a mutant target to the discriminating probe is unfavorable; therefore, the beads remain dispersed. An image of each microwell is obtained and processed to generate a saturation value corresponding to the extent of aggregation. The Journal of Molecular Diagnostics 2016 18, 546-553DOI: (10.1016/j.jmoldx.2016.02.004) Copyright © 2016 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 2 KRAS mutation analysis of lung cancer and colorectal cancer cell lines. Using a PCR-derived target sequence, each cell line was analyzed using the HIAMD assay. The results indicate a significant decrease in the extent of aggregation produced by cell lines bearing a KRAS mutation (SW-620 and H2122) as compared to wild-type cell lines (CaCo2 and H1975). Data are expressed as means ± SD. n = 3 per group. The Journal of Molecular Diagnostics 2016 18, 546-553DOI: (10.1016/j.jmoldx.2016.02.004) Copyright © 2016 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 3 Resolution of mutant (mut) DNA in a background of wild-type (WT) DNA. HIAMD was applied for the analysis of synthetic samples with mixed genotypes. All samples with mutant content (down to 25% mutant) were significantly distinguishable from a wild-type sample. Data are expressed as means ± SD. n = 3 per group. The Journal of Molecular Diagnostics 2016 18, 546-553DOI: (10.1016/j.jmoldx.2016.02.004) Copyright © 2016 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 4 KRAS mutation analysis of patient tissue samples. A: Representative sequencing results of three patient samples. (Note: the reverse strand was sequenced). B: HIAMD results. Aggregation of 36% was used as the threshold value to distinguish between wild-type (≥36%) and mutant (<36%) genotypes. Patient numbers are displayed on the x axis. Data are expressed as means ± SD. The Journal of Molecular Diagnostics 2016 18, 546-553DOI: (10.1016/j.jmoldx.2016.02.004) Copyright © 2016 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions